$54.77
-0.22-0.40%
At close: Aug 6, 5:00 PM EST
$55.86
1.091.99%
After Hours: 5:01 PM EST
AnaptysBio (ANAB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.66 | $0.92 | $-1.17 | $-1.55 |
| Actual | $-1.84 | $1.58 | $0.52 | $-1.34 |
| Surprise | -178.8% | +71.7% | +144.4% | +13.6% |
| Revenue | ||||
| Estimate | $18.9M | $86.0M | $25.6M | $13.5M |
| Actual | $25.6M | $108.2M | $76.3M | $22.3M |
| Surprise | +35.4% | +25.9% | +198.7% | +64.7% |
| Metric | Q2 '26E | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.07 | $0.33 | $0.45 | $-0.06 |
| Revenue | ||||
| Consensus | $21.6M | $28.1M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | May 12, 2026 | $-1.84 | $-0.66 | -178.8 % |
| Q4 | Mar 3, 2026 | $1.58 | $0.92 | 71.7 % |
| Q3 | Nov 4, 2025 | $0.52 | $-1.17 | 144.4 % |
| Q2 | Aug 6, 2025 | $-1.34 | $-1.55 | 13.6 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 12, 2026 | $25.56M | $18.87M | 35.4 % |
| Q4 | Mar 3, 2026 | $108.24M | $85.96M | 25.9 % |
| Q3 | Nov 4, 2025 | $76.32M | $25.55M | 198.7 % |
| Q2 | Aug 6, 2025 | $22.26M | $13.52M | 64.7 % |